Cognitive impairment still common but ART reduces risk
From 'what if' to 'what now': implementing the new prevention technologies
Maraviroc improves liver fibrosis in HIV/hepatitis C co-infected patients
Treatment as prevention: what are the next steps?
Small study shows women on stable HIV therapy have very low levels of HIV and high drug concentrations in genital fluids
Raltegravir combined with Kaletra associated with good preservation of bone density over 96 weeks
South Africa's PMTCT programme reduces mother-to-child transmission to under 4%
Viral suppression reduces HIV risk despite more sex and 'condom fatigue' in patients starting treatment in Cameroon
Daily aciclovir slows HIV disease progression and reduces viral load
Testing project using social networks in rural Tanzania effective in identifying people with undiagnosed infection
How best to deploy point-of-care CD4 cell testing in resource-limited settings?
Pre-exposure prophylaxis does work for women, two studies find
HPTN 052: early treatment reduces serious illness by 40%
Treatment is prevention: HPTN 052 study shows 96% reduction in transmission when HIV-positive partner starts treatment early
Bacterial vaginosis raises women's risk of transmitting HIV
Marker of cardiovascular disease also associated with bone problems in patients with HIV
Doubt remains if HIV therapy increases the risk of fragility fractures
